refractory | OSU MedNet21

Learn About Refractory Depression on Webcast. Learners will be given the definition of refractory depression and learn how to identify refractory depression in their patient population. Next the presentation will go through algorithm of depression treatment followed by explanation of interventional depression treatment options as well as second line medications that can be used.

To discuss refractory depression, we’ve invited one of Ohio State University’s Psychiatry experts. We’re pleased to introduce Dr Evita Singh, Assistant Professor of Psychiatry and Behavioral Health. Evita is trained in Child & Adolescent Psychiatry and is also an interventional psychiatrist.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

Discuss benefits and risks of medication treatment options for refractory depression
Introduce interventional options for refractory depression

You’ll also learn about the following:

Interventional Psychiatry
SSRI Black Box Warning
Measuring Improvement
Titration and Follow-up
Lithium
Interventional Therapies

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Refractory Depression on CME Webcast. We now have additional treatments for resistant depression that are expanding the therapeutic options for these patients. And we’re going to hear about these treatments in today’s webcast. Let us welcome our guests. Dr. Subhdeep Virk is an Associate Professor of Psychiatry at the Ohio State University. And Dr. Kevin Reeves is an Assistant Professor of Psychiatry here at OSU.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: define and screen depression and Treatment Resistant Depression; discuss therapeutic options for treating Refractory Depression; become aware of resources to evaluate treatment history; and compare and contrast transcranial magnetic stimulation, electroconvulsive therapy, intranasal esketamine and electroconvulsive therapy.

You’ll also learn about the following:

Epidemiology of treatment resistant depression
Electroconvulsive therapy today
When to refer patients to a psychiatrist?
When to admit patients

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.